They make their debuts as Prof. Remus Lupin (Rheon) and Peter Pettigrew (Harrison) in "Prisoner of Azkaban," released by ...
Werewolf Therapeutics, Inc. develops modified cytokines for cancer treatment, including WTX-124, a modified IL-2, and WTX-330, a modified IL-12. Xilio Therapeutics out-licensed their modified IL-12 to ...
Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...
A company says it has brought the dire wolf back from extinction and posted videos showing the two animals. Colossal Biosciences posted a video to its X site showing the dire wolf pups howling. The ...
Werewolf Therapeutics (NASDAQ:HOWL) just reported results for the second quarter of 2024. Werewolf Therapeutics reported earnings per share of -43 cents. This was below the analyst estimate for EPS of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results